Effectiveness of chronic obstructive pulmonary disease-management programs: Systematic review and meta-analysis

被引:97
作者
Peytremann-Bridevaux, Isabelle [1 ]
Staeger, Philippe [2 ]
Bridevaux, Pierre-Olivier [3 ]
Ghali, William A. [4 ,5 ]
Burnand, Bernard [1 ,6 ]
机构
[1] CHU Vaudois, Healthcare Evaluat Unit, Inst Social & Prevent Med, CH-1005 Lausanne, Switzerland
[2] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland
[3] Univ Hosp Geneva, Dept Med, Div Pulm Care, Geneva, Switzerland
[4] Univ Calgary, Dept Med, Calgary, AB, Canada
[5] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[6] Univ Montreal, Fac Med, Grp Rech Gest Therapeut, Montreal, PQ H3C 3J7, Canada
关键词
chronic obstructive pulmonary disease; disease management; effectiveness; meta-analysis; systematic review; quality of care;
D O I
10.1016/j.amjmed.2008.02.009
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
BACKGROUND: Disease-management programs may enhance the quality of care provided to patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD). The aim of this systematic review was to assess the effectiveness of COPD disease-management programs. METHODS: We conducted a computerized search of MEDLINE, EMBASE, CINAHL, PsychINFO, and the Cochrane Library (CENTRAL) for studies evaluating interventions meeting our operational definition of disease management: patient education, 2 or more different intervention components, 2 or more health care professionals actively involved in patients' care, and intervention lasting 12 months or more. Programs conducted in hospital only and those targeting patients receiving palliative care were excluded. Two reviewers evaluated 12,749 titles and fully reviewed 139 articles; among these, data from 13 studies were included and extracted. Clinical outcomes considered were all-cause mortality, lung function, exercise capacity (walking distance), health-related quality of life, symptoms, COPD exacerbations, and health care use. A meta-analysis of exercise capacity and all-cause mortality was performed using random-effects models. RESULTS: The studies included were 9 randomized controlled trials, 1 controlled trial, and 3 uncontrolled before-after trials. Results indicate that the disease-management programs studied significantly improved exercise capacity (32.2 m, 95% confidence interval [CI], 4.1-60.3), decreased risk of hospitalization, and moderately improved health-related quality of life. All-cause mortality did not differ between groups (pooled odds ratio 0.84, 95% CI, 0.54-1.40). CONCLUSION: COPD disease-management programs modestly improved exercise capacity, health-related quality of life, and hospital admissions, but not all-cause mortality. Future studies should explore the specific elements or characteristics of these programs that bring the greatest benefit. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:433 / U125
页数:15
相关论文
共 47 条
[1]
Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management [J].
Adams, Sandra G. ;
Smith, Paulla K. ;
Allan, Patrick F. ;
Anzueto, Antonio ;
Pugh, Jacqueline A. ;
Cornell, John E. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (06) :551-561
[2]
[Anonymous], GLOB STRAT DIAGN MAN
[3]
[Anonymous], DIS MANAGEMENT
[4]
Effectiveness of disease management programs in depression: A systematic review [J].
Badamgarav, E ;
Weingarten, SR ;
Henning, JM ;
Knight, K ;
Hasselblad, V ;
Gano, A ;
Ofman, JJ .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (12) :2080-2090
[5]
Reduction of hospital utilization in patients with chronic obstructive pulmonary disease -: A disease-specific self-management intervention [J].
Bourbeau, J ;
Julien, M ;
Maltais, F ;
Rouleau, M ;
Beaupré, A ;
Bégin, R ;
Renzi, P ;
Nault, D ;
Borycki, E ;
Schwartzmann, K ;
Singh, R ;
Collet, JP .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :585-591
[6]
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[7]
Chronic obstructive pulmonary disease [J].
Calverley, PMA ;
Walker, P .
LANCET, 2003, 362 (9389) :1053-1061
[8]
Integrated care prevents hospital isations for exacerbations in COPD patients [J].
Casas, A. ;
Troosters, T. ;
Garcia-Aymerich, J. ;
Roca, J. ;
Hernandez, C. ;
Alonso, A. ;
del Pozo, F. ;
de Toledo, P. ;
Anto, J. M. ;
Rodriguez-Roisin, R. ;
Decramer, M. .
EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (01) :123-130
[9]
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[10]
*COCHR LIB, 2006, COCHRANE HDB SYSTEMA